CITIUS PHARMAC (Germany) Probability of Future Stock Price Finishing Over 7.8
| 47N Stock | EUR 3.29 0.00 0.00% |
CITIUS |
CITIUS PHARMAC Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CITIUS PHARMAC for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CITIUS PHARMAC DL can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| CITIUS PHARMAC DL generated a negative expected return over the last 90 days | |
| CITIUS PHARMAC DL has high historical volatility and very poor performance | |
| CITIUS PHARMAC DL has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (23.66 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| CITIUS PHARMAC DL has accumulated about 115.66 M in cash with (22.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.79. |
CITIUS PHARMAC Technical Analysis
CITIUS PHARMAC's future price can be derived by breaking down and analyzing its technical indicators over time. CITIUS Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of CITIUS PHARMAC DL. In general, you should focus on analyzing CITIUS Stock price patterns and their correlations with different microeconomic environments and drivers.
CITIUS PHARMAC Predictive Forecast Models
CITIUS PHARMAC's time-series forecasting models is one of many CITIUS PHARMAC's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary CITIUS PHARMAC's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about CITIUS PHARMAC DL
Checking the ongoing alerts about CITIUS PHARMAC for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for CITIUS PHARMAC DL help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| CITIUS PHARMAC DL generated a negative expected return over the last 90 days | |
| CITIUS PHARMAC DL has high historical volatility and very poor performance | |
| CITIUS PHARMAC DL has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (23.66 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| CITIUS PHARMAC DL has accumulated about 115.66 M in cash with (22.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.79. |
Other Information on Investing in CITIUS Stock
CITIUS PHARMAC financial ratios help investors to determine whether CITIUS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CITIUS with respect to the benefits of owning CITIUS PHARMAC security.